Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
Current human papillomavirus (HPV) vaccines provide substantial protection against the most common HPV types responsible for oral and anogenital cancers, but many circulating cancer-causing types remain for which vaccine coverage is lacking. In addition, all current HPV vaccines rely on aluminum sal...
Saved in:
Main Authors: | Sarah M. Valencia (Author), Athina Zacharia (Author), Alexander Marin (Author), Rebecca L. Matthews (Author), Chia-Kuei Wu (Author), Breana Myers (Author), Chelsea Sanders (Author), Simone Difilippantonio (Author), Reinhard Kirnbauer (Author), Richard B. Roden (Author), Ligia A. Pinto (Author), Robert H. Shoemaker (Author), Alexander K. Andrianov (Author), Jason D. Marshall (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracellular Delivery of Active Proteins by Polyphosphazene Polymers
by: Bareera Qamar, et al.
Published: (2021) -
Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
by: Javier Pérez Quiñones, et al.
Published: (2022) -
Design and Synthesis of Amphiphilic Graft Polyphosphazene Micelles for Docetaxel Delivery
by: Diana Serbezeanu, et al.
Published: (2023) -
RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021) -
Zika virus-like particle (VLP) based vaccine.
by: Hélène Boigard, et al.
Published: (2017)